IN

INVITES BIOCORE CO., LTD

A CRO advancing precision medicine via genomic analysis and clinical trial support services.

216400 | KO

Overview

Corporate Details

ISIN(s):
KR7216400002
LEI:
Country:
South Korea
Address:
서울특별시 금천구 디지털로9길 33, 금천구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Invites Biocore Co., Ltd. is a biotechnology company and Contract Research Organization (CRO) established in 2001. The company specializes in supporting new drug development and advancing precision medicine. Its core services include bioanalytical testing, central lab services, clinical trial support, and genetic and cell screening, with a focus on individual genomic analysis. By leveraging advanced technology, Invites Biocore partners with domestic and international pharmaceutical companies, research institutes, and medical institutions to facilitate personalized healthcare and support the data-based bio healthcare industry throughout the R&D lifecycle.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-04 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 91.6 KB
2025-06-17 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2025-06-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-05-21 00:00
Regulatory News Service
조회공시요구(풍문또는보도) (영업활동의 일부정지)
Korean 3.4 KB
2025-05-21 00:00
Regulatory News Service
주권매매거래정지 (풍문 또는 보도 관련)
Korean 5.0 KB
2025-05-21 00:00
Regulatory News Service
조회공시요구(풍문또는보도)에대한답변(부인)
Korean 5.4 KB
2025-05-21 00:00
Delisting Announcement
주권매매거래정지해제 (풍문 등 조회결과 공시)
Korean 4.3 KB
2025-04-30 00:00
Notice of Dividend Amount
[기재정정]현금ㆍ현물배당결정 (중간배당)
Korean 19.0 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.7 KB
2025-03-26 00:00
Board/Management Information
대표이사변경
Korean 10.1 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 15.5 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 2.1 MB
2025-03-13 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 200.7 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 8.7 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 170.3 KB

Automate Your Workflow. Get a real-time feed of all INVITES BIOCORE CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INVITES BIOCORE CO., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for INVITES BIOCORE CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

KOLON CORPORATION Logo
A holding company for diverse businesses in materials, chemicals, fashion, and life sciences.
South Korea
002020
kt nasmedia Co., Ltd. Logo
An integrated digital marketing platform for data-driven online, mobile, and OOH ad solutions.
South Korea
089600
Kubota Pharmaceutical Holdings Co., Ltd. Logo
Developing ophthalmic drugs and devices to preserve and restore vision for patients globally.
Japan
4596
Kweather Co., Ltd. Logo
Provider of weather data, air quality monitoring, and enterprise climate management solutions.
South Korea
068100
Kymera Therapeutics, Inc. Logo
Fintech firm providing data analytics and market intelligence for investment professionals.
United States of America
KYMR
LABCORP HOLDINGS INC. Logo
Provides diagnostic lab testing and biopharma drug development services for healthcare clients.
United States of America
LH
LAMAR ADVERTISING CO/NEW Logo
A leading OOH advertising REIT with billboards, transit, and airport displays in the US & Canada.
United States of America
LAMR
Larimar Therapeutics, Inc. Logo
Clinical-stage biotech developing protein therapies for rare diseases like Friedreich's ataxia.
United States of America
LRMR
LEAP THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing targeted immuno-oncology antibody therapies for cancer.
United States of America
LPTX
Lidds AB Logo
Develops oncology drugs using a technology for local, controlled, and sustained drug release.
Sweden
LIDDS

Talk to a Data Expert

Have a question? We'll get back to you promptly.